Lastly, we confirm here that CASP1 and CASP6 mRNA levels are significantly increased in specific regions of the AD brains in the ADNI cohort compared to cognitively normal control brains from large sample sizes in the AMP-AD Consortium. This evidence concerns the gene CASP1 and Alzheimer disease.